Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

 John M. Baumann

John M. Baumann

University of Louisville Louisville USA

Dr Chan Hong Park

Dr Chan Hong Park

Chairman, Neurosurgery/ Spine Surgery Daegu Wooridul Spine Hospital Incheon South Korea

Dr. Tatsuo Ido

Dr. Tatsuo Ido

Chaired person & Director, Pharmaceutical Science Gachon University South Korea

 Irene Treacy

Irene Treacy

Director of Smovey Health Smovey Health Dublin Ireland

George Perry

George Perry

Dean The University of Texas USA

Dr.Elena Frid

Dr.Elena Frid

Neurologist Robert Wood Johnson Medical School USA

Walter Bini

Walter Bini

Consultant Neurosurgeon, Orthopedic Department Healthpoint Hospital United Arab Emirates

Eric M. Massicotte

Eric M. Massicotte

Neurosurgeon ,MD, MSc, FRCS(C) , Neurosurgery University of Toronto Canada

Recommended Global Neuroscience Webinars & Conferences

Europe & UK
Asia Pacific & Middle East
Canada

Parkinsons-2023

About Conference


We are pleased to have you join us at the "22nd International Conference on Parkinson's Diseases," which will be held in Milan city, Italy on March 29–30, 2023. The conference's organising theme is "A Strong Determination to Evolve Advanced Medication." World-class professionals in the fields of neurology and neuroscience will run ICPD-2023. To discuss specific topics in the field of neurology, such as clinical neurophysiology, neurosurgery, neuron muscular disorders, neuron infectious diseases, paediatric neurology, neuropathology, brain tumours, and neuron-oncology, among others, international symposiums, B2B meetings, and workshops will also be organised. The goal of the conference is to understand the mechanisms underpinning human cognition by identifying the genetic causes of prevalent illnesses. Disorders of neurogenesis are widespread in both industrialised and developing nations. Congenital issues and genetic disorders.

ICPD-2023 encourage participants from all top academic institutions and clinical research labs to share their research on all facets of this quickly expanding subject, meet with top researchers, and display the most recent methods. Parkinson's 2023 is an annual gathering of Neurologists, Neurosurgeons Psychiatrists, Research Scholars, to discuss the future of neurological disorders in terms of collaboration and organizational development.

Why to Attend?                                                                    

ICPD-2023 will bring together experts like Neuroscientists, Clinicians, Neurogeneticst, Neurologists, Psychiatrists, Medical practitioners, Care specialists, academic professionals  and students from all over the world to share an interest in the genetic pathways underlying neurological disorders, techniques to identify those genetic pathways, and the use of genetics and genomics as tools to develop therapeutics.

The aim of the conference is to provide a platform to academicians and practitioners from to debate and deliberate on social change that is encompassed by innovation and multiple disciplines technology.

Target Audience

  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Specialists
  • Researchers
  • Health care professionals
  • Professors
  • Industrial Experts
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Scientists
  • Lecturers and Students from Academia
  • Students from Academia in the research of Neurology

Sessions and Tracks

Track 1: : Neuroanatomy

Neuroanatomy is the study of the composition and operation of the nervous system. Bilateral symmetry animals have segregated, developed neural systems as opposed to radial symmetry animals, which have a scattered cell network in their nervous systems. The inner structure of the brain and spinal cord (often referred to as the CNS) and the nerve pathways that connect to the rest of the body make up the two components of the nervous system in vertebrates (known as the peripheral nervous system, or PNS).

Track 2: Neurology

The area of medicine known as neurology is dedicated to the examination and study of nervous system problems. The central nervous system and peripheral nervous system, which include their coverings, blood vessels, and all effector tissue, such as muscle, are the two major divisions of the nervous system, which is a complicated, practical system that regulates and coordinates bodily activity. A neurologist is a medical professional who specialises in neurology. a neurologist who has received special training to examine, identify, and manage a neurological condition that affects the brain, spinal cord, and nerves.

Track 3: Neuromuscular Disorders

Neuromuscular illnesses affect the nerves that regulate your own voluntary muscles. Your arms and legs are two instances of voluntary muscles that humans can independently control. The signals that control these muscles are transmitted by your neurons, which are also referred to as your nerve cells. When neurons deteriorate or die, the communication between your nervous system and muscles is hampered. As a result, your muscles start to deteriorate and weaken, which can lead to twitching, cramps, aches, pains, and problems with your joints and range of motion. It frequently affects how well your heart and lungs function as well.

  • Amyotrophic lateral sclerosis
  • Multiple sclerosis
  • Myasthenia gravis

Track 4: Neurorehabilitation

About 70% of rehabilitation instances involve neurorehabilitation. There is severe neuronal damage following an accident or stroke, which may result in temporary or permanent disability. Learning new abilities, getting used to the new routine, and avoiding difficulties are all important aspects of rehabilitation. The doctors should be open and honest with the patients, helping them maintain an optimistic outlook despite their despair, and being realistic about the recovery process and refraining from making empty promises.ICPD-2023 is necessary for people with strokes, brain injuries, spinal cord injuries, neurodegenerative diseases including Parkinson's, Alzheimer's, and ataxias, post-traumatic procedures, and paediatric conditions like cerebral palsy.

Track 5: Neuropharmacology

Neuropharmacology is the study of how drugs affect the neural system through which they affect expression as well as how they affect cellular activity in the nervous system. Neuropharmacology has two subspecialties: behavioural and molecular. The study of how drugs impact mortal gestation (neuropsychopharmacology), including how drug habit and dependence affect the mortal brain, is a major emphasis of behavioural science. In order to create drugs that have positive effects on neurological function, molecular neuropharmacology studies neurons and their neurochemical interactions.

  • Recent drug development
  • Neuroimmuno pharmacology
  • Neuro chemical interaction
  • neuropharmacologcal therapy
  • Genome wide association studies

Track 6: Neurogenetic & Neurometabolic Disorders

Neurogenetics and Neuro metabolic disorders can both have an impact on how the brain functions. They affect young children of all ages, races, and genders. A wide range of chronic illnesses known as "neurogenetic diseases" include brain abnormalities brought on by changes in a child's DNA, which lead to some brain cells developing and acting incorrectly. When it comes to Neuro metabolic abnormalities, these illnesses are caused by problems with the body's cell enzymes, which can either not use food to create the energy cells need or can not get rid of the breakdown products of the food the cell used.

Track 7: Neurosurgery

The diagnosis and treatment of patients with injuries to, or diseases/disorders of, the brain, spinal cord, spinal column, and peripheral nerves in all regions of the body are the focus of this medical speciality. Patients of all ages are treated in the neurosurgical discipline. A neurological surgeon may offer surgical and non-surgical care depending on the kind of injury or disease.

Track 8: Neuropsychiatric

Neuropsychiatry, also referred to as organic psychiatry, is a branch of medicine that studies the interaction between psychiatry and neurology with the goal of understanding and attributing behaviour to the interaction of neurobiology and social psychological factors.  Neuropsychiatry considers the mind to be "an emergent component of the brain," in contrast to other behavioural and neurological specialties that may see them as distinct entities. Neuropsychiatry was the predecessor to the present medical specialties of psychiatry and neurology, which historically shared training. However, both fields have since divided and are now commonly practised separately.

Track 9: Novel Therapeutic

Oxford researchers are enhancing the results for cancer patients around the world by creating new medicines and optimising the use of ones that already exist. Due to a combination of surgery, radiation therapy, and several drugs, 50% of patients with cancer can expect to be cured or live for more than 10 years. To keep raising the percentage of cancer patients who are cured, existing therapies must be applied and combined in the best possible ways, and new therapies must be created. Oxford Cancer aspires to ensure that knowledge gained from fundamental scientific developments such as Cell Biology & Tissue Physiology and Physical Sciences & Drug Discovery is applied to enhance cancer treatments by coordinating research through this theme.

Track 10: Brain cell death

Brain death is the total, irreversible loss of all brain functions, including the involuntary functions required to maintain life. It contrasts from a chronic vegetative state, where the person is still ICPD-2023 and still has some autonomic functioning. As long as some bodily and mental function is still there, it differs from comas. It also isn't the same as the syndrome known as "locked-in syndrome." These many illnesses can be medically distinguished via a differential diagnosis. Many jurisdictions utilize brain death as a sign of legal death; however the term is inconsistently defined and frequently misunderstood by the general public. The phrase "brain death" has been used to refer to situations in which some areas of the brain continue to function even when others do not.

Track 11: Multiple Sclerosis

A disorder of the central nervous system that can be crippling is multiple sclerosis (MS) (brain and spinal cord). In MS, the protective sheath (myelin) covering nerve fibres are attacked by the immune system, impairing brain and body connection. In the long run, the condition may weaken or permanently harm the nerves. Depending on the extent of nerve damage and which nerves are affected, MS symptoms can vary greatly. While those with no new symptoms may experience prolonged periods of remission, some persons with severe MS may lose their ability to walk independently or at all. Multiple sclerosis symptoms can vary greatly from person to person and during the course of the illness.

Track 12: Clinical Neurophysiology

The study of the central and peripheral nerve systems through the documentation of bioelectrical activity, whether spontaneous or induced, is known as clinical neurophysiology. It entails the study of pathophysiology as well as medical techniques ICPD-2023 disorders of the peripheral and central nervous systems. Clinical neurophysiology examinations extend beyond those carried out in a lab. The electrical activity of the brain, the spinal cord, and the nerves in the limbs and muscles is measured during tests.

  • Electromyography
  • Electroencephalography
  • Evoked potentials
  • Polysomnography
  • Intraoperative monitoring

Track13: Multiple System Atrophy

 Multiple system atrophy (MSA) is a rare neurodegenerative complaint characterized by autonomic dysfunction, temblors, slow movement, muscle severity, and postural in security and ataxia. This is caused by progressive degeneration of neurons in several corridor of the brain including the rudimentary ganglia, inferior Oliver nexus, and cerebellum. Numerous people affected by MSA experience dysfunction of the autonomic nervous system, which generally manifests as orthostatic hypotension, incompetence, loss of sweating, dry mouth and urinary retention and incontinence. Palsy of the oral cords is an important and ICPD-2023 original clinical incarnation of the complaint. A modified form of the nascence-syncline protein within affected neurons may beget MSA. About 55 of MSA cases do in men, with those affected first showing symptoms at the age of 50-60 times. MSA frequently presents with some of the same symptoms as Parkinson's complaint. Those with MSA generally show little response to the dopamine specifics used to treat Parkinson's complaint and only about 9 of MSA cases with earthquake parade a true Parkinson lozenge- rolling earthquake.

Track 14: Drug-induced Parkinsonism

Parkinsonism isn't technically a opinion, but rather a set of symptoms including slowness, stiffness, rest earthquake, and problems with walking and balance. This set of symptoms can be caused by PD, but also can do as a side effect of certain tradition specifics. A number of specifics can beget Parkinsonism because they block the dopamine receptor and thereby mimic the symptoms of PD that are caused by loss of dopamine neurons in the brain. Reviewing a case’s specifics is thus a critical step for a neurologist when seeing someone with Parkinsonism. Anti-psychotics andante-nausea treatments make up the bulk of the problematic specifics, although there are other specifics that can also beget Parkinsonism. The primary treatment for this type of Parkinsonism is weaning off of the offending drug, if possible.

Track 15: Vascular Parkinsonism (VP)

Vascular parkinsonism (VP), performing from cerebrovascular complaint, is a rare complaint showing a variety of clinical and pathological donations distinct from sporadic Parkinson’s complaint (PD). It accounts for 3-6 of all parkinsonian runs, and is delicate to diagnose with clinical certainty. Clinical features include bilateral symmetrical severity; bradykinesia, generally involving lower branches; postural insecurity; shuffling gait; madness and corticospinal findings.Neuropathology shows multiple subcortical ischemic lesions owing to small vessel complaint in striatum Globus pallid us, white matter and, substantial nagar, involving cortico-striato-pallidal, thalamofrontal and other Circles, without substantiation of Lowy bodies. Cranial reckoned tomography and glamorous resonance imaging are useful tests to estimate the vascular lesions. Functional imaging of presynaptic dopamine transporter may be useful in the isolation of VP from PD. Response to levodopa treatment has been reported in over to 50 of VP cases,  particularly in those with lesions in or close to nigrostriatal pathways, although only a many  cases demonstrate long- term efficacity.

Market Analysis

ICPD-2023 will focus on the exciting and latest innovations in all areas of Neurology, Neuroscience research, Parkinson’s and Neurodegenerative Diseases which offers a unique opportunity for investigators across the globe to network, meet and perceive new interactive scientific innovations. This year’s ICPD-2023 highlights the theme, “A Strong Determination to Evolve Advanced Medication” which reflects the ground-breaking progress in neurology and neuroscience research.

The two days conference includes Neuroscience workshops, Neurology symposiums and Neurology keynote sessions conducted by renowned and eminent speakers who excel in the field of Neurology which includes all the topics related to Neurology and Neuroscience.

This ICPD-2023 Conference also encourages the participation of upcoming researchers, young students, and scientists as we are hosting Neurology Poster Award competition and Neurology Young research Forum at the conference.

        Parkinsons-2023

ICPD-2023 as vitally charmed by Neurology Nobel laureates, Neurology International Symposiums and Neurology Workshops, Neurology Keynotes get-togethers, Exhibitions and Delegates those who are interested in the field of Neurology and Neuroscience.

Fund Allotment (in Million Dollars) to Parkinson’s and Neurodegenerative Diseases Research: 

The worldwide neuroscience showcase estimate was esteemed at USD 28.42 billion out of 2016 and is relied  upon to develop at a CAGR of 3.1% over the gauge time frame. High impacting factors, for example, continuous mind mapping examination and examination ventures, neuroscience based activities by government bodies, and innovative advances in instruments and calculations that are actualized in neuroscience space, are required to drive the market development. These elements are foreseen to support income age by impelling the item appropriation in this market all through the gauge year.

Market Analysis of Parkinson’s and Neurodegenerative Diseases Research:

The general neuroscience showcase incorporates diverse innovations for cerebrum imaging and neuromicroscopy alongside the recently created and developing methods for neuron biochemical measures. Entire cerebrum imaging, Neuro microscopy, and electrophysiology innovations represented around 47% piece of the overall induct.

Statistics of Physicians, Researchers, and Academicians working on Neuroscience:

The part of the world related with Neurology field are Deans, Professors, Directors, Heads, Researchers, Doctors, Scientists, Students and Writers of Neuroscience Department and in addition Employees and Founders of the related organizations, Associations individuals, labs individuals related society and Pharma individuals, and so on.

Following are the statistics percentage-wise:

                      2017

6.4%

                      2019

19.2%

                      2021

34.6%

                      2023

43.8%

                      2025

51.4%

New York, Sept. 25, 2017 (GLOBE NEWSWIRE) - With solid CAGR of 6.4%, the worldwide neuroscience market is probably going to develop from US$ 301.6 Mn in 2016 to US$ 520.8 Mn by 2025 end. This development is principally fuelled by headway in neuroimaging and expanding R and D in neuroinformatics. "Neuroscience Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)," is the new production of Persistence Market Research that spotlights on merger and obtaining, key coordinated efforts and innovation, and innovation move understandings, which assume a crucial job in the global neuroscience advertise. North America and Europe are relied upon to command the global neuroscience showcase in the surveyed time of 8-years that is somewhere in the range of 2017 and 2025.

To Collaborate Scientific Professionals around the World

Conference Date March 29-30, 2023

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

International Journal of Emergency Mental Health and Human Resilience Journal of Neuroinfectious Diseases Journal of Alzheimers Disease & Parkinsonism

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner